Incidence of hyperlipidemia in kidney transplant patients treated with a combination regimen of sirolimus(Rapa)-cyclosporine(CsA)-prednisone(Pred)

被引：3
|
作者：
Suri, A
Kahan, BD
机构：
[1] Univ Texas, Sch Med, Div Immunol & Organ Transplantat, Houston, TX 77030 USA
[2] Univ Texas, Sch Med, Div Nephrol, Houston, TX 77030 USA
来源：
TRANSPLANTATION | 1999年 / 67卷 / 07期
关键词：
D O I：
10.1097/00007890-199904150-00671
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
646
引用
下载
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [31] TRANSPLANT ACUTE TUBULAR-NECROSIS (ATN) IN CYCLOSPORINE (CSA)-TREATED PATIENTS (PTS)
    SOLEZ, K
    RACUSEN, LC
    BURDICK, JF
    KEOWN, PA
    OLSEN, S
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 495 - 495
  • [32] CHRONIC REJECTION IN 500 KIDNEY-TRANSPLANT PATIENTS TREATED WITH CYCLOSPORINE - INCIDENCE AND RISK-FACTORS
    PALLARDO, LM
    SANCHEZ, J
    PUIG, N
    SANCHEZ, P
    BENEYTO, I
    CRESPO, J
    ROS, F
    ROCHERA, A
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (04) : 2215 - 2216
  • [33] Is Mycophenolate Mofetil and Sirolimus Combination a Safe Regimen for Maintenance Immunosuppression In Liver Transplant Patients?
    Bhat, Ishfaq
    Lyden, Elizabeth
    McCashland, Timothy
    Grant, Wendy
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (02) : 187 - 187
  • [34] Basiliximab-sirolimus-prednisone induction regimen followed by delayed low-dose cyclosporine in renal transplant recipients of living donors
    Langer, RM
    Hong, DM
    Katz, SM
    Van Buren, CT
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (08) : 3162 - 3164
  • [35] A pilot study of steroid withdrawal from kidney transplant recipients on sirolimus-cyclosporine a combination therapy
    Mahalati, K
    Kahan, BD
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3232 - 3233
  • [36] Incidence of post transplant diabetes (PTDM) in kidney recipients treated with neoral (CsA) and prograf (FK).
    Kumar, MSA
    Kumar, AMS
    Panigrahi, D
    Bloom, R
    Pankewycz, O
    Phillips, K
    Seirka, D
    McSorely, M
    Lyons, P
    Brezin, J
    Chvala, R
    TRANSPLANTATION, 1999, 67 (07) : S168 - S168
  • [37] CANCER INCIDENCE IN RENAL-TRANSPLANT PATIENTS TREATED WITH AZATHIOPRINE OR CYCLOSPORINE
    SHELL, AGR
    FLAVEL, S
    DISNEY, APS
    MATHEW, TH
    HALL, BM
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 2214 - 2216
  • [38] PREDICTORS OF GRAFT LOSS IN 197 PREGNANCIES IN CYCLOSPORINE-TREATED (CSA) FEMALE KIDNEY-TRANSPLANT RECIPIENTS
    ARMENTI, VT
    CATER, JR
    RADOMSKI, JS
    GAUGHAN, WJ
    MORITZ, MJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 993 - 993
  • [39] Therapy of hyperlipidemia with lovastatin in kidney transplant patients on cyclosporine a immunosuppression: Three-year experience
    Kandus, A
    Kovac, D
    Cerne, D
    Koselj, M
    Kaplan-Pavlovcic, S
    Buturovic, J
    Ponikvar, R
    Kveder, R
    Lindic, J
    Bren, AF
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1307 - 1309
  • [40] Population pharmacokinetics of mycophenolic acid in adult kidney transplant patients under prednisone and tacrolimus regimen
    Eduardo Resendiz-Galvan, Juan
    Romano-Aguilar, Melissa
    Edith Medellin-Garibay, Susanna
    del Carmen Milan-Segovia, Rosa
    del Carmen Nino-Moreno, Perla
    Jung-Cook, Helgi
    Alejandro Chevaile-Ramos, Jose
    Romano-Moreno, Silvia
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 150
12345